Salem Radio Network News Monday, September 27, 2021

Health

Stevanato Group, maker of COVID-19 vaccine vials, eyes $7 billion valuation in U.S. IPO

(Reuters) – Italy’s Stevanato Group S.p.A., a maker of glass vials for COVID-19 vaccine and other healthcare products, said on Wednesday it is seeking a valuation of over $7 billion in its initial public offering in the United States.

(Reporting by Niket Nishant in Bengaluru; Editing by Bernard Orr)

Previous
Next

Editorial Cartoons

View More »

Michael Ramirez
Sun, Sep 26, 2021

X CLOSE